ARID1A and gastric cancer: Together, these results identify ARID1A promoter hypermethylation as a critical driver of gastric cancer progression and highlight the therapeutic potential of 5-aza-CdR in HGC-27 cells via promoting apoptosis and suppressing proliferation and invasion.